Clinical Trial Update: Adebrelimab Infusion Plus Standard Care for Pancreatic Cancer With Pleural or Peritoneal Effusions [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Adebrelimab in combination with standard care for metastatic pancreatic cancer with pleural or peritoneal effusions; the study is not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: Sizhen Wang | Conditions: Pancreatic Cancer Metastatic | Phase 2 | Status: NOT_YET_RECRUITING